title: Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias.
authors.affiliation: UO Oncoematologia, Fondazione Istituto Di Ricovero E Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: Bruno
authors.initials: B
authors.lastname: Fattizzo
authors.affiliation: UO Oncoematologia, Fondazione Istituto Di Ricovero E Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Zaninoni
authors.affiliation: UO Oncoematologia, Fondazione Istituto Di Ricovero E Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Nesa
authors.affiliation: UO Oncoematologia, Fondazione Istituto Di Ricovero E Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: Veronica M
authors.initials: VM
authors.lastname: Sciumbata
authors.affiliation: UO Oncoematologia, Fondazione Istituto Di Ricovero E Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Zanella
authors.affiliation: UO Oncoematologia, Fondazione Istituto Di Ricovero E Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico; Università Degli Studi Di Milano, Milano, Italy.
authors.forename: Agostino
authors.initials: A
authors.lastname: Cortelezzi
authors.affiliation: UO Oncoematologia, Fondazione Istituto Di Ricovero E Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: Wilma
authors.initials: W
authors.lastname: Barcellini
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D004912:Erythrocytes / Q000187:drug effects / Q000473:pathology; D006461:Hemolysis; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077269:Lenalidomide; D010951:Plasma Exchange; D000069283:Rituximab; D012720:Severity of Illness Index; D013156:Splenectomy; D013256:Steroids / Q000627:therapeutic use*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D061665:Time-to-Treatment; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D013256:Steroids; D000069283:Rituximab; D013792:Thalidomide; D000077269:Lenalidomide